We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





World's First Urinary Catheter Stabilizer That Actively Prevents Accidental Extractions Introduced at MEDICA 2021

By HospiMedica International staff writers
Posted on 15 Nov 2021

CATHETRIX (Tel-Aviv, Israel) presented its new catheter stabilizer for the prevention of urinary tract infections (UTI) and accidental Foley catheter extractions at MEDICA 2021, which took place November 15–18 in Dusseldorf, Germany. More...

CATHETRIX’s new Foley/Safe 2.0 Catheter Securement Device is the world’s first Foley catheter stabilizer that actively prevents accidental extractions. Foley/Safe 2.0 prevents catheter dislodgement and movement to reduce the risk of catheter associated UTI. The innovative catheter stabilizer prevents unintentional and accidental urinary catheter extraction, thus avoiding damage and strictures to the bladder or urethra. Once the Foley catheter is pulled with a force that can harm the patient, Foley/Safe 2.0 will cut the sterile fluid tube and let the retention balloon deflate, permitting the catheter to slide out safely. Foley/Safe 2.0 provides two-layer protection securement to patients with Foley catheters, latex and silicone.

Medical studies have shown that 11-17% of all catheters are unintentionally extracted and 5% of all urological catheters are traumatically pulled out. Some 25% of all hospitalized patients, as well as people confined to bed in hospices and nursing homes, have urinary catheters. Many of these inpatients tend to dislodge their catheter tube, thereby causing themselves unnecessary pain, injury and increased risk of damage and infections. Foley/Safe safely prevents surgery and expensive hospitalization. The device has been patented and has received US FDA and EU CE Mark clearances.

Related Links:
CATHETRIX 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Tourniquet System
heidi– mein Tourniquet
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.